3,190 results on '"Wedemeyer, Heiner"'
Search Results
2. Hepatotoxizität durch Albendazol: sichere Alternativen bei Echinokokkosetherapie
3. Safety and efficacy of conventional compared to segmented esophageal fully covered self-expanding metal stents: a retrospective multicenter case–control study
4. Percutaneous transhepatic biliary drainage in patients with cholestasis following liver transplantation
5. Hepatitis E virus: from innate sensing to adaptive immune responses
6. Value of systemic inflammation markers for the detection of minimal and prediction of overt hepatic encephalopathy after TIPS insertion
7. Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infections
8. Limited stability of Hepatitis B virus RNA in plasma and serum
9. Patient profiled data for treatment decision-making: valuable as an add-on to hepatitis C clinical guidelines?
10. Clinical significance of transjugular liver biopsy in acute liver failure – a real-world analysis
11. Genetic determinants of host- and virus-derived insertions for hepatitis E virus replication
12. Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis
13. Correction to: Diagnosis and Management of Hepatitis Delta Virus Infection
14. Diagnosis and Management of Hepatitis Delta Virus Infection
15. Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosis
16. Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis
17. Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide
18. Novel translational mouse models of metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesity
19. QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis
20. Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
21. HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
22. Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial
23. Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis
24. High Prevalence and Clinical Relevance of Intrapulmonary Vascular Dilatations in Patients Undergoing TIPS Implantation
25. Folic acid supplementation is associated with a decreased mortality and reduced hospital readmission in patients with decompensated alcohol-related liver cirrhosis
26. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta
27. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
28. CXCR6+CD69+ CD8+ T cells in ascites are associated with disease severity in patients with cirrhosis
29. Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies
30. Hepatitis B surface antigen expression impairs endoplasmic reticulum stress-related autophagic flux by decreasing LAMP2
31. Weissbuch Gastroenterologie 2023/24
32. Tg1.4HBV-s-rec mice, a crossbred hepatitis B virus-transgenic model, develop mild hepatitis
33. Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis
34. Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
35. BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis—a study protocol for a multicenter, randomized, controlled parallel group trial
36. Next Generation Sequencing Outperforms Cultivation-Based Methods for Detection of Bacterial Genera in Bile After Liver Transplantation
37. HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replication
38. HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
39. Elevated Plasma CXCL8 Concentrations in Significant Fibrosis but Not in Subclinical Rejection After Adult Liver Transplantation
40. Gastroenterologinnen und Gastroenterologen positionieren sich!
41. Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests
42. Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
43. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
44. A global research priority agenda to advance public health responses to fatty liver disease
45. No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
46. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
47. EASL Clinical Practice Guidelines on hepatitis delta virus
48. Hepatitis D: Looking Back, Looking Forward, Seeing the Reward and the Promise
49. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application
50. Immunological scars after cure of hepatitis C virus infection: Long‐HepC?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.